Fred Hutchinson
Immunization in cancer survivors: Optimizing response, minimizing risk
The COVID-19 pandemic has underscored the importance of vaccination, both in terms of protecting individuals from infection and eradicating threats to public health.
Videos reduce HPV vaccine hesitancy among parents
During a communication experiment, brief videos of a pediatrician announcing to parents that their child is due for an HPV vaccine and easing their concerns reduced HPV vaccine hesitancy, data showed.
Screening strategies could reduce prostate cancer mortality, overdiagnosis among Black men
Of the known racial disparities in cancer incidence and mortality, the disproportionate burden of prostate cancer among Black men remains one of the most pronounced.
FDA grants priority review to maribavir for refractory cytomegalovirus infection
The FDA granted priority review to maribavir for the treatment of patients with transplant-associated cytomegalovirus infection that was resistant or refractory to prior treatment, according to the agent’s manufacturer.
FDA clears IND application for CD20-directed CAR-T to treat B-cell malignancies
The FDA cleared an investigational new drug application for MB-106, a chimeric antigen receptor T-cell therapy designed to treat patients with relapsed or refractory, CD20-positive B-cell malignancies.
Bisphosphonates may lower risk for invasive breast cancer among women with DCIS
Bisphosphonate use among women with a history of ductal carcinoma in situ appeared associated with lower risk for subsequent invasive breast cancer, according to study results published in Cancer Research.
Tumor-infiltrating lymphocytes show ‘dramatic’ results in metastatic melanoma
More than 80% of patients with heavily pretreated metastatic melanoma experienced tumor shrinkage after receiving the adoptive cell therapy lifileucel, according to results of a phase 2 study.
Bispecific CAR-T shows early efficacy, ‘exceptional safety’ in advanced B-cell lymphoma
Four of five patients with relapsed or refractory B-cell lymphoma demonstrated complete response to an investigational anti-CD19/CD20 chimeric antigen receptor T-cell therapy, according to early data from a phase 1 trial.
Speaker: Focusing COVID-19 vaccine research on patients with cancer an ongoing challenge
The lack of patients with cancer in COVID-19 vaccine trials has led to a major gap in data to understand how these vaccines work for this population, according to a keynote address at the COVID-19 & Cancer Consortium Scientific Retreat.
Patients with cancer living in poorer areas have worse survival outcomes
Cancer clinical trial participants living in poorer neighborhoods had worse OS, PFS and cancer-specific survival than those from affluent areas, according to results of a retrospective study published in Journal of Clinical Oncology.